An atlas of active enhancers across human cell types and tissues
Mette Boyd(University of Copenhagen), A. Maxwell Burroughs(National Institutes of Health), Christian Schmidl(Leibniz Association), Frederik Otzen Bagger(Copenhagen University Hospital), Yutaka Negishi(CE Technologies (United Kingdom)), Ilka Hoof(University of Copenhagen), Peter Refsing Andersen(Aarhus University), Mette Jørgensen(Copenhagen University Hospital), Takahiro Suzuki(University of Miami), Yuri Ishizu(CE Technologies (United Kingdom)), J. Kenneth Baillie(NHS Lothian), Berit Lilje(University of Copenhagen), Nicolas Rapin(University of Copenhagen), Erina Furuhata(RIKEN Center for Integrative Medical Sciences), Johanna Raithel(University Hospital Regensburg), Jette Bornholdt(University of Copenhagen), Dagmar Glatz(University Hospital Regensburg), Lucia Schwarzfischer(University Hospital Regensburg), Eivind Valen(University of Oslo), Owen J. L. Rackham(University of Southampton), Irene Miguel-Escalada(University of Birmingham), Nicolas Bertin(Harvard University), Robin Andersson(Broad Institute), Claudia Gebhard(University Hospital Regensburg), Yun Chen(Johns Hopkins University), Kang Li(Nanjing Agricultural University), Yuri Shimizu, Xiaobei Zhao(University of North Carolina at Chapel Hill), Chris Mungall(Lawrence Berkeley National Laboratory), Shiori Maeda(RIKEN Center for Integrative Medical Sciences), Evgenia Ntini(FORTH Institute of Molecular Biology and Biotechnology)
Cited by 0
Related Papers
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence for dynamically organized modularity in the yeast protein–protein interaction network
|Nature|2004|1.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k